Marta María
Alonso Roldán
Profesional Investigadora


Dana–Farber Cancer Institute
Boston, Estados UnidosPublications in collaboration with researchers from Dana–Farber Cancer Institute (5)
2025
2024
2023
-
Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways
Cancer Discovery, Vol. 13, Núm. 11, pp. 2370-2393
-
TIM-3 blockade in diffuse intrinsic pontine glioma models promotes tumor regression and antitumor immune memory
Cancer Cell, Vol. 41, Núm. 11, pp. 1911-1926.e8
2016
-
Critical role of autophagy in the processing of adenovirus capsid-incorporated cancer-specific antigens
PLoS ONE, Vol. 11, Núm. 4